Bruno Pougault/LinkedIn
Jul 16, 2026, 12:07
Bruno Pougault: ISTH 2026 Paris Highlights – Looking Ahead
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared a post on LinkedIn:
“ISTH 2026 Paris Highlights: Looking Ahead
What an inspiring week at ISTH 2026 in Paris!
- Novel hemostasis therapies continue to improve efficacy while aiming to reduce bleeding risk.
- Advances in gene and RNA-based approaches are opening new perspectives for rare bleeding disorders.
- Next-generation diagnostics are enabling earlier and more precise patient stratification.
- AI-powered analytics and digital tools are accelerating clinical decision-making and personalized care.
- Global collaborations are strengthening access to innovation and evidence-based medicine.
- Emerging data in thrombosis and hemostasis are reshaping the future of patient management.
- Paris once again proved to be a unique crossroads of art, culture, and science, providing an inspiring setting for innovation and exchange.
- A sincere thank you to the ISTH organizers, speakers, partners, and participants for an outstanding congress.
Goodbye Paris, and thank you for the unforgettable moments, scientific excellence, and international connections.
Let’s keep looking to the future and transforming innovation into better outcomes for”

Other posts featuring Bruno Pougault on Hemostasis Today.
-
Oct 18, 2026, 08:02Neda Ashayeri: Global Perspectives on Hemophilia and Rare Bleeding Disorders in Abu Dhabi
-
Oct 18, 2026, 07:55Anu Thomas: A Stepwise Laboratory Approach to Positive IAT and Pretransfusion Compatibility
-
Oct 18, 2026, 07:49Matthew Hazell: Molecular Matching and the Future of Transfusion Practice
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH